# A Study to Test How BI 1819479 is Taken up and Processed by the Body

> **NCT07065617** · PHASE1 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 7 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]BI 1819479
- **DRUG:** BI 1819479
- **DRUG:** BI 1819479 (C-14)

## Key facts

- **NCT ID:** NCT07065617
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-08-04
- **Primary completion:** 2025-10-04
- **Final completion:** 2025-11-04
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Company decision
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07065617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07065617, "A Study to Test How BI 1819479 is Taken up and Processed by the Body". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07065617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*